LITHE 发表于 2025-3-27 00:46:01

http://reply.papertrans.cn/23/2220/221932/221932_31.png

Basal-Ganglia 发表于 2025-3-27 02:36:49

http://reply.papertrans.cn/23/2220/221932/221932_32.png

冒烟 发表于 2025-3-27 09:07:35

http://reply.papertrans.cn/23/2220/221932/221932_33.png

B-cell 发表于 2025-3-27 11:33:42

Tritium as a Stratospheric Tracer,s. In the subsequent two chapters, we aim to provide a pragmatic discussion on some of the key priorities and unique challenges faced when considering primary and secondary prevention of ASCVD in older patients. We will use the ABCDE approach as a framework for the discussion, highlighting current i

GUISE 发表于 2025-3-27 17:01:26

http://reply.papertrans.cn/23/2220/221932/221932_35.png

烦扰 发表于 2025-3-27 17:50:37

Nickolai A. Tchurikov,Natalia A. Ponomarenkol and improving quality of life, reflect this trend . Compared to a younger cohort, the elderly population generally has higher rates of comorbid disease with lower functional reserve, ultimately predisposing them to a higher risk of complications and death. This increased risk, paired with the i

加入 发表于 2025-3-28 00:36:22

https://doi.org/10.1007/978-3-642-73958-3ecause of poor prognosis and increased risk of adverse events. Physicians should be aware of the available evidence regarding the safety and efficacy of pharmacological and interventional therapies in older patients for the best possible outcome. Rather than using a “one size fits all” approach, the

有危险 发表于 2025-3-28 04:34:59

http://reply.papertrans.cn/23/2220/221932/221932_38.png

anagen 发表于 2025-3-28 07:33:58

http://reply.papertrans.cn/23/2220/221932/221932_39.png

有抱负者 发表于 2025-3-28 11:38:44

http://reply.papertrans.cn/23/2220/221932/221932_40.png
页: 1 2 3 [4] 5
查看完整版本: Titlebook: Cardiovascular Disease in the Elderly; Thorsten M. Leucker,Gary Gerstenblith Book 2023Latest edition The Editor(s) (if applicable) and The